Loading...
Loading...
Application UK00918097979 · Registered
| Application Number | UK00918097979 |
| Status | Registered |
| Owner | Wave Life Sciences Ltd. |
| Filed | 2019-07-22 |
| Registered | 2019-12-06 |
| Renewal Due | 2029-07-22 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. PRISM is currently a registered UK trademark, with renewal due on 2029-07-22. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for use in targeted gene silencing; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies.
Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders.
Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing.
'PRISM' is a registered trademark on the UK IPO register, owned by Wave Life Sciences Ltd.. The application (UK00918097979) was filed on 22 July 2019 and registered on 6 December 2019. The registration is set to expire on 22 July 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 40 (treatment of materials & manufacturing services); Class 42 (scientific, IT & design services).
The trademark is represented by William Fry LLP.
UK trademark UK00918097979 for the mark 'PRISM' in Class 5, 40, 42 is recorded on the UK IPO register as owned by Wave Life Sciences Ltd.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00918097979 for the mark 'PRISM' as registered.
UK trademark UK00918097979 for the mark 'PRISM' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 40 (treatment of materials & manufacturing services); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; oligonucleotide compounds for use in targeted gene sil…
UK trademark UK00918097979 for the mark 'PRISM' was filed at the UK IPO on 22 July 2019 and registered on 6 December 2019.
UK trademark UK00918097979 for the mark 'PRISM' is currently recorded as valid until 22 July 2029, at which point it will need to be renewed with the UK IPO to remain in force.
William Fry LLP is listed as the attorney / representative of record for UK trademark UK00918097979 for the mark 'PRISM' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "PRISM" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| TRANSMISSION PRISM | 99678151 | 630 | 2026-03-02 |
| PRISM-REVIEWS.COM | 99678599 | 630 | 2026-03-02 |
| THE CAREER PRISM NETWORK | 99668065 | 630 | 2026-02-24 |
| THE CAREER PRISM METHOD | 99668138 | 630 | 2026-02-24 |
| PRISM DRUG DESIGN PLATFORM | 99651674 | 630 | 2026-02-13 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| PRISM | 2613677 | published | 2025-12-18 |
| SCHEDULE PRISM | 2588963 | accepted | 2025-09-25 |
| QUALICAPS PRISM G | 2562834 | protected | 2025-07-03 |
| Prism Crystals by Lovisa | 2561164 | protected | 2025-06-27 |
| PRISM Energy International Australia | 2546394 | protected | 2025-05-22 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.